Evidence map›Paper›PMID 35976268›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2022

Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action.

C I S Medeiros, M N A de Sousa, G G A Filho, F O R Freitas, D P L Uchoa, M S C Nobre, A L D Bezerra, L A D M M Rolim, A M B Morais, T B S S Nogueira and 3 more

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Antibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Life (Basel, Switzerland) · 2024
    Article
  13. Biological activity of the essential oil ofFrontiers in chemistry · 2024
    Review
  14. Natural Compounds with Antifungal Properties againstAntibiotics (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Review
  17. The Volatile Organic Compounds ofMicroorganisms · 2023
    Article
  18. Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

C I S MedeirosDepartamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, João Pessoa, PB, Brasil.ORCID http://orcid.org/0000-0002-6413-8303
M N A de SousaCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0001-8327-9147
G G A FilhoCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0001-5071-7964
F O R FreitasCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-1675-8487
D P L UchoaCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-4602-4222
M S C NobreCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-9186-9988
A L D BezerraCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-0547-5772
L A D M M RolimCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-2527-3772
A M B MoraisCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-4441-9714
T B S S NogueiraCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-5717-340X
R B S S NogueiraCurso de Medicina, Centro Universitário UniFIP, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-5676-6748
A A O FilhoUnidade Acadêmica de Ciências Biológicas (UACB), Universidade Federal de Campina Grande, Patos, PB, Brasil.ORCID http://orcid.org/0000-0002-7466-9933
E O LimaDepartamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, João Pessoa, PB, Brasil.ORCID http://orcid.org/0000-0002-9547-0886
Centro Universitário Assunção · BRUniversidade Federal da Paraíba · BRUniversidade Federal de Campina Grande · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is the most frequently isolated opportunistic pathogen in the female genital tract, with 92.3% of cases in Brazil associated with vulvovaginal candidiasis (VVC). Linalool is a monoterpene compound from plants of the genera Cinnamomum, Coriandrum, Lavandula, and Citrus that has demonstrated a fungicidal effect on strains of Candida spp., but its mechanism of action is still unknown. For this purpose, broth microdilution techniques were applied, as well as molecular docking in a predictive manner for this mechanism. The main results of this study indicated that the C. albicans strains analyzed were resistant to fluconazole and sensitive to linalool at a dose of 256 µg/mL. Furthermore, the increase in the minimum inhibitory concentration (MIC) of linalool in the presence of sorbitol and ergosterol indicated that this molecule possibly affects the cell wall and plasma membrane integrity of C. albicans. Molecular docking of linalool with proteins that are key in the biosynthesis and maintenance of the cell wall and the fungal plasma membrane integrity demonstrated the possibility of linalool interacting with three important enzymes: 1,3-β-glucan synthase, lanosterol 14α-demethylase, and Δ 14-sterol reductase. In silico analysis showed that this monoterpene has theoretical but significant oral bioavailability, low toxic potential, and high similarity to pharmaceuticals. Therefore, the findings of this study indicated that linalool probably causes damage to the cell wall and plasma membrane of C. albicans, possibly by interaction with important enzymes involved in the biosynthesis of these fungal structures, in addition to presenting low in silico toxic potential.

Indexed as

Candida albicansFluconazoleAcyclic MonoterpenesAntifungal AgentsDrug Resistance, FungalMicrobial Sensitivity TestsMolecular Docking SimulationMonoterpenesAcyclic MonoterpenesAntifungal AgentsFluconazolelinaloolMonoterpenes

Identifiers

PMID35976268
PMCPMC9377531
OpenAlexW4291567107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.